Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001311837 | SCV000653142 | likely benign | not provided | 2025-01-26 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001311837 | SCV002525281 | uncertain significance | not provided | 2024-05-22 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Observed in an individual with leiomyosarcoma (PMID: 28878254); This variant is associated with the following publications: (PMID: 24807215, 20951805, 28878254, 38201563, 35534704) |
Sema4, |
RCV002257831 | SCV002536788 | likely benign | Hereditary cancer-predisposing syndrome | 2020-12-09 | criteria provided, single submitter | curation | |
Ambry Genetics | RCV002257831 | SCV005479473 | likely benign | Hereditary cancer-predisposing syndrome | 2024-07-08 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |